Atlas Trials

To Evaluate the Efficacy and Safety of TYNADOTE® in the Treatment of Acetaminophen Overdose

Clinical trial NCT05557448 · RECRUITING

Trial details

NCT number
NCT05557448
Sponsor
Sinew Pharma Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis
Start date
2023-05-01
Primary completion
2026-12-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.